The present Competitive Intelligence Report about CEA Antagonists provides a competitor evaluation in the field of investigational antibodies and vaccines targeting carcinoembryonic antigen (CEA) for treatment of cancer as of April 2009.
The report includes a compilation of current active projects in research and development of epithelial cell adhesion molecule (EpCAM) targeting antibodies and antibody-based constructs. In addition, the report lists company-specific R&D pipelines of EpCAM Antagonists. Competitor projects are listed in a tabular format providing information on:
- Drug Codes, - Target / Mechanism of Action, - Class of Compound, - Company, - Product Category, - Indication, - R&D Stage and - additional comments with a hyperlink leading to the source of information.
